BEAM- Beam Therapeutics Inc.
Beam Therapeutics Inc. (BEAM) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 36 sells. BEAM is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.01M | $35.94M | - | |
| Pres | 218.4K | $7.76M | - | |
| Other | 109.7K | $3.90M | - | |
| Other | 77.4K | $2.75M | - | |
| CFO | 73.7K | $2.62M | - |
Activity
Buys and sells only
Transactions
5 filings · page 8
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28, 2021 | Cooper Graham K | Director | Sale+OE | 12,045 | $106.34 | $1,280,896.71 | -49.6% | -12.9% | -62.9% | |
| Apr 21, 2021 | Evans John M.70 | CEO | Sale+OE | 25,000 | $70.49 | $1,762,215.61 | -0.5% | +27.8% | -43.3% | |
| Jan 4, 2021 | Burrell Terry-Ann81 | CFO | Sale+OE | 25,000 | $81.78 | $2,044,484.79 | -15.2% | - | - | |
| Dec 30, 2020 | Ciaramella Giuseppe77 | President &CSO | Sale+OE | 43,842 | $83.26 | $3,650,143.58 | -16.4% | - | - | |
| Dec 30, 2020 | Evans John M.70 | CEO | Sell | 22,300 | $84.94 | $1,894,124.84 | -0.3% | - | - |
← PrevPage 8